歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁 > 小分子抑制劑 > CytoskeletalSignaling > Pamidronic Acid See P172500

瀏覽歷史

S80699

Pamidronic Acid See P172500

源葉(MedMol) 98%
  • 英文名:
  • Pamidronic Acid See P172500
  • 別名:
  • CAS號(hào):
  • 40391-99-9
  • 分子式:
  • C3H11NO7P2
  • 分子量:
  • 235.07
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購物車...
源葉(MedMol) S80699-10mg 98% ¥350.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購物車
源葉(MedMol) S80699-50mg 98% ¥530.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購物車
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說明書。
  • 產(chǎn)品描述: Pamidronic acid is a drug used to treat a broad spectrum of bone absorption diseases.
  • 靶點(diǎn): Wnt, β-catenin;Wnt/beta-catenin
  • 體內(nèi)研究:
    Pamidronic acid can significantly inhibit and even reverse early osteoarthritic subchondral bone loss, thus alleviating the process of cartilaginous degeneration. The mechanisms involved may be associated with the upregulation of OPG expression, and downregulation of RANKL, MMP-9 and TLR-4 expression
  • 參考文獻(xiàn):
    1. Ashton JA, et al. Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cellsfrom dogs. Am J Vet Res. 2005 May;66(5):885-91. 2. Xu Y, et al. Pamidronate Disodium Leads to Bone Necrosis via Suppression of Wnt/β-Catenin Signaling in Human Bone Marrow Mesenchymal Stem Cells In Vitro. J Oral Maxillofac Surg. 2017 Mar 22. 3. Lv Y, et al. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. BMC Musculoskelet Disord. 2014 Nov 6;15:370.
  • 溶解性: Soluble  in  DMSO、H2O
  • 保存條件: 2-8℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 4.254 ml 21.27 ml 42.541 ml
    5 mM 0.851 ml 4.254 ml 8.508 ml
    10 mM 0.425 ml 2.127 ml 4.254 ml
    50 mM 0.085 ml 0.425 ml 0.851 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
  • 提示:詳情請(qǐng)下載說明書。
  • 產(chǎn)品描述: Pamidronic acid is a drug used to treat a broad spectrum of bone absorption diseases.
  • 靶點(diǎn): Wnt, β-catenin;Wnt/beta-catenin
  • 體內(nèi)研究:
    Pamidronic acid can significantly inhibit and even reverse early osteoarthritic subchondral bone loss, thus alleviating the process of cartilaginous degeneration. The mechanisms involved may be associated with the upregulation of OPG expression, and downregulation of RANKL, MMP-9 and TLR-4 expression
  • 參考文獻(xiàn):
    1. Ashton JA, et al. Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cellsfrom dogs. Am J Vet Res. 2005 May;66(5):885-91. 2. Xu Y, et al. Pamidronate Disodium Leads to Bone Necrosis via Suppression of Wnt/β-Catenin Signaling in Human Bone Marrow Mesenchymal Stem Cells In Vitro. J Oral Maxillofac Surg. 2017 Mar 22. 3. Lv Y, et al. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. BMC Musculoskelet Disord. 2014 Nov 6;15:370.
  • 溶解性: Soluble  in  DMSO、H2O
  • 保存條件: 2-8℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 4.254 ml 21.27 ml 42.541 ml
    5 mM 0.851 ml 4.254 ml 8.508 ml
    10 mM 0.425 ml 2.127 ml 4.254 ml
    50 mM 0.085 ml 0.425 ml 0.851 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。
点击收缩